Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/13/2008EP1581471B9 Cyclopentenone derivatives for cancer therapy
08/13/2008EP1572672B1 Benzoxazocines and their use as monoamine-reuptake inhibitors
08/13/2008EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
08/13/2008EP1572196B1 Combination of a dpp-iv inhibitor and a ppar-alpha compound
08/13/2008EP1567193B1 Colon cleansing compositions
08/13/2008EP1565183B1 Rapamycin and il-10 for the treatment of autoimmune diseases
08/13/2008EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity
08/13/2008EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
08/13/2008EP1537867B1 Method of photodynamic diagnosis for vascular diseases
08/13/2008EP1513556B1 A process for the preparation of piroxicam: b-cyclodextrin inclusion compounds
08/13/2008EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
08/13/2008EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof
08/13/2008EP1497290B1 Process for preparing acid salts of gemifloxacin
08/13/2008EP1497263B1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
08/13/2008EP1497250B1 Hyperforin derivatives, the use thereof and formulations containing them
08/13/2008EP1496905B1 Modulators of hedgehog signaling pathways, compositions and uses related thereto
08/13/2008EP1495030B1 Non-steroidal progesterone receptor modulators
08/13/2008EP1494673B1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use
08/13/2008EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
08/13/2008EP1489076B1 Cyclic hemiacetal derivative and use thereof
08/13/2008EP1467993B1 Method for producing scopine esters
08/13/2008EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function
08/13/2008EP1461042B1 Use of desoxypeganine for treating clinical depression
08/13/2008EP1458390B1 A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008EP1452528B1 Xanthine oxidase inhibitors
08/13/2008EP1437354B1 4-oxoquinolizine antimicrobials having 2-pyridone skeleton as partial structure
08/13/2008EP1436279B1 Chemical compounds
08/13/2008EP1435945B1 Topical migraine therapy
08/13/2008EP1435874B1 Implantable devices for treatment of pain by delivery of fentanyl and fentanyl congeners
08/13/2008EP1429914B1 Apparatus for manufacturing dosage forms
08/13/2008EP1427379B1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
08/13/2008EP1421946B1 A pharmaceutical composition for treating hiv infection
08/13/2008EP1420782B1 Use of nefiracetam for treating post-stroke neurodegeneration
08/13/2008EP1389098B1 Delivery of antipsychotics through an inhalation route
08/13/2008EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route
08/13/2008EP1386923B1 Novel adenine derivatives
08/13/2008EP1368305B1 7, 9-substituted tetracycline compounds
08/13/2008EP1339282B1 Hydrophilic polymer blends used for dry cow therapy
08/13/2008EP1332231B1 Methods for measuring drug resistance
08/13/2008EP1331924B1 Use of beta-carotene and lycopene for treating ageing symptoms via the inhibition of the expression of the metalloproteinase of type 1 of the extracellular matrix
08/13/2008EP1324761B1 Uridine therapy for patients with elevated purine levels
08/13/2008EP1322309B1 High affinity small molecule c5a receptor modulators
08/13/2008EP1289916B1 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
08/13/2008EP1272636B1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
08/13/2008EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby
08/13/2008EP1181023B1 Compositions of polyacids, non-ionic polymers consisting of alkylene oxide monomers and multivalent cations and their use in reducing adhesions
08/13/2008EP1137773B1 Growth factor homolog zvegf3
08/13/2008EP1082029B1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
08/13/2008EP1020445B1 Fused pyridine derivatives
08/13/2008EP0996448B1 Treatment and prevention of adhesions
08/13/2008EP0942928B2 Subunit respiratory syncytial virus vaccine preparation
08/13/2008EP0936913B1 Oral pharmaceutical preparation containing ibandronat
08/13/2008EP0934924B1 Novel diamide compounds and drugs containing the same
08/13/2008EP0894140B1 Allele suppression
08/13/2008EP0669987B1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
08/13/2008EP0647137B1 Glycine receptor antagonists and the use thereof
08/13/2008CN101243184A Nucleic acid for treatment or prevention of immunodeficiency virus infection
08/13/2008CN101243103A Therapeutic agent for hypertension
08/13/2008CN101243102A Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
08/13/2008CN101243101A Homogemcitabines
08/13/2008CN101243096A 抗病毒化合物 Antiviral compounds
08/13/2008CN101243093A New oxabispidine compounds for the treatment of cardiac arrhythmias
08/13/2008CN101243092A Cripowellins and synthetic derivatives thereof used as medicaments
08/13/2008CN101243091A Tricyclic compounds useful as 5-serotonin inhibitors and 5-HT1A agonists and antagonists
08/13/2008CN101243090A P38 MAP kinase inhibitors and methods for using the same
08/13/2008CN101243089A Halogenated pyrazolo [1,5-A]pyrimidines, processes, uses as GABA-A receptors ligand, compositions and intermediates
08/13/2008CN101243088A P38 MAP kinase inhibitors and methods for using the same
08/13/2008CN101243087A 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
08/13/2008CN101243086A Indoli zine derivatives and their use as CRTH2 antagonists
08/13/2008CN101243085A Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
08/13/2008CN101243084A Pyrrolo[2,3-B]pyridine derivatives as protein kinase inhibitors
08/13/2008CN101243083A Naphthyridine compounds
08/13/2008CN101243082A Hexahydro-pyrrolo-isoquinoline compounds for the treatment of CNS disorders
08/13/2008CN101243081A Pyrido[2,3-d]pyrimidine-2,4-diamine compounds as PTP1B inhibitors
08/13/2008CN101243080A Pyrazolo[3,4-B]pyridin-2-yl]-benzoic acid derivatives as HIV integrase inhibitors
08/13/2008CN101243079A Tricyclic opioid modulators
08/13/2008CN101243078A Thiazolyl piperidine derivatives useful as h3 receptor modulators
08/13/2008CN101243077A New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions
08/13/2008CN101243076A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
08/13/2008CN101243075A Novel 2,3-dihydroindole compounds
08/13/2008CN101243074A Heterocyclic compounds
08/13/2008CN101243073A Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor
08/13/2008CN101243071A Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
08/13/2008CN101243070A Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
08/13/2008CN101243069A Thrombin inhibiting 2-oxo-1,2,5,6-tetrahydropyridine derivatives
08/13/2008CN101243066A Delta and epsilon crystal forms of imatinib mesylate
08/13/2008CN101243063A Sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents
08/13/2008CN101243058A Oxadiazole derivatives as DGAT inhibitors
08/13/2008CN101243056A Crystal of phenylalanine derivative, process for producing the same and use thereof
08/13/2008CN101243055A Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors
08/13/2008CN101243053A N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/13/2008CN101243052A Helix 12 directed non-steroidal antiandrogens
08/13/2008CN101243051A P38 MAP kinase inhibitors and methods for using the same
08/13/2008CN101243048A 1-acyldihydropyrazol derivatives
08/13/2008CN101243047A Phenoxy acetic acids as PPAR delta activators
08/13/2008CN101243046A Acylguanidine derivative or salt thereof
08/13/2008CN101243045A New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
08/13/2008CN101243044A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
08/13/2008CN101243043A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
1 ... 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 ... 7860